Joana Gonçalves

Dr. Joana Gonçalves

University of Coimbra, Coimbra, Portugal
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2010 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
Joana GonçalvesJoana Gonçalves
Joana Gonçalves
SBSofia Baptista
Sofia Baptista
TMTânia Martins
Tânia Martins
NMNuno Milhazes
Nuno Milhazes
Fernanda BorgesFernanda Borges
Fernanda Borges
ASAna Paula Silva
Ana Paula Silva

13 February 2022 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
SSSofia Santos
Sofia Santos
HFHelena Ferreira
Helena Ferreira
JMJoão Martins
João Martins
Joana GonçalvesJoana Gonçalves
Joana Gonçalves
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
Neurodevelopmental disorders are characterized by relatively early onset, with temporal variations across conditions. These lifelong conditions lead to social and communication impairments, and cognitive deficits. In recent years, the importance of biological sex as a vital factor determining behavioural and cognitive vulnerability has been substantiated with a direct impact on both diagnosis and therapeutic response. Several theories have been raised as an attempt to explain psychiatric sex bias. These include the extreme male brain theory, female protective effect, maternal stress, and perinatal inflammation. Here, we address this issue in the context of three important neurodevelopmental disorders where male bias exists into variable extents: autism spectrum disorder (ASD), attention deficit/hyperactivity disorder (ADHD), and schizophrenia (SCZ). Sex differences in behaviour and brain organization are reviewed both for patient and animal research, in the context of molecular theories that may explain differential disease vulnerability. Accumulating evidence suggests a complex mechanistic scenario, with genetic predisposition and endocrine and environmental factors as interacting components governing disease onset, progression, and severity.

8 May 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
RFRaquel Ferreira
Raquel Ferreira
TSTiago Santos
Tiago Santos
Joana GonçalvesJoana Gonçalves
Joana Gonçalves
GBGraça Baltazar
Graça Baltazar
LFLino Ferreira
Lino Ferreira
LBLiliana Bernardino
Liliana Bernardino
Background: Histamine is commonly acknowledged as an inflammatory mediator in peripheral tissues, leaving its role in brain immune responses scarcely studied. Therefore, our aim was to uncover the cellular and molecular mechanisms elicited by this molecule and its receptors in microglia-induced inflammation by evaluating cell migration and inflammatory mediator release. Methods: Firstly, we detected the expression of all known histamine receptor subtypes (H1R, H2R, H3R and H4R), using a murine microglial cell line and primary microglia cell cultures from rat cortex, by real-time PCR analysis, immunocytochemistry and Western blotting. Then, we evaluated the role of histamine in microglial cell motility by performing scratch wound assays. Results were further confirmed using murine cortex explants. Finally, interleukin-1beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) levels were evaluated by ELISA measurements to determine the role of histamine on the release of these inflammatory mediators. Results: After 12 h of treatment, 100 μM histamine and 10 μg/ml histamine-loaded poly (lactic-co-glycolic acid) microparticles significantly stimulated microglia motility via H4R activation. In addition, migration involves α5β1 integrins, and p38 and Akt signaling pathways. Migration of microglial cells was also enhanced in the presence of lipopolysaccharide (LPS, 100 ng/ml), used as a positive control. Importantly, histamine inhibited LPS-stimulated migration via H4R activation. Histamine or H4R agonist also inhibited LPS-induced IL-1β release in both N9 microglia cell line and hippocampal organotypic slice cultures. Conclusions: To our knowledge, we are the first to show a dual role of histamine in the modulation of microglial inflammatory responses. Altogether, our data suggest that histamine per se triggers microglia motility, whereas histamine impedes LPS-induced microglia migration and IL-1β release. This last datum assigns a new putative anti-inflammatory role for histamine, acting via H4R to restrain exacerbated microglial responses under inflammatory challenge, which could have strong repercussions in the treatment of CNS disorders accompanied by microglia-derived inflammation.

1 September 2011 in Brain Research
Verified
Journal Article
Closed access
TMTânia Martins
Tânia Martins
SBSofia Baptista
Sofia Baptista
Joana GonçalvesJoana Gonçalves
Joana Gonçalves
ELErmelindo Carreira Leal
Ermelindo Carreira Leal
NMNuno Milhazes
Nuno Milhazes
ASAna Paula Silva
Ana Paula Silva

6 October 2008 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Joana GonçalvesJoana Gonçalves
Joana Gonçalves
TMTânia Martins
Tânia Martins
RFRaquel Ferreira
Raquel Ferreira
NMNuno Milhazes
Nuno Milhazes
Fernanda BorgesFernanda Borges
Fernanda Borges
ASAna Paula Silva
Ana Paula Silva

19 September 2017 in Molecular Autism
Verified
Journal Article
Open access
PDF file
Joana GonçalvesJoana Gonçalves
Joana Gonçalves
IVInês R. Violante
Inês R. Violante
JSJosé Sereno
José Sereno
RLRicardo Alexandre Leitão
Ricardo Alexandre Leitão
YCYing Cai
Ying Cai
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
Excitation/inhibition (E/I) imbalance remains a widely discussed hypothesis in autism spectrum disorders (ASD). The presence of such an imbalance may potentially define a therapeutic target for the treatment of cognitive disabilities related to this pathology. Consequently, the study of monogenic disorders related to autism, such as neurofibromatosis type 1 (NF1), represents a promising approach to isolate mechanisms underlying ASD-related cognitive disabilities. However, the NF1 mouse model showed increased γ-aminobutyric acid (GABA) neurotransmission, whereas the human disease showed reduced cortical GABA levels. It is therefore important to clarify whether the E/I imbalance hypothesis holds true. We hypothesize that E/I may depend on distinct pre- and postsynaptic push-pull mechanisms that might be are region-dependent. In current study, we assessed two critical components of E/I regulation: the concentration of neurotransmitters and levels of GABA(A) receptors. Measurements were performed across the hippocampi, striatum, and prefrontal cortices by combined in vivo magnetic resonance spectroscopy (MRS) and molecular approaches in this ASD-related animal model, the Nf1 +/− mouse. Cortical and striatal GABA/glutamate ratios were increased. At the postsynaptic level, very high receptor GABA(A) receptor expression was found in hippocampus, disproportionately to the small reduction in GABA levels. Gabaergic tone (either by receptor levels change or GABA/glutamate ratios) seemed therefore to be enhanced in all regions, although by a different mechanism. Our data provides support for the hypothesis of E/I imbalance in NF1 while showing that pre- and postsynaptic changes are region-specific. All these findings are consistent with our previous physiological evidence of increased inhibitory tone. Such heterogeneity suggests that therapeutic approaches to address neurochemical imbalance in ASD may need to focus on targets where convergent physiological mechanisms can be found.